Big drug company CEOs to testify at Senate Health committee on insulin prices
Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health-care spending is on people with diabetes.
Why markets actually could be hoping for a recession this year
Despite the ominous economic headwinds, markets have held tough.
DHS task force will examine how to use A.I. to protect homeland security
Secretary Alejandro Mayorkas said the technology could potentially be used to better screen for imports of goods produced by forced labor as well as fentanyl.
Biden to order all federal agencies to prioritize environmental justice
Biden’s new Office of Environmental Justice in the White House will coordinate all environmental justice efforts across the federal government.
Virginia GOP Gov. Glenn Youngkin dodges 2024 questions as he gears up for Asia trip
Youngkin’s trip will occur the same time that Florida Gov. Ron DeSantis, seen as Donald Trump’s top potential GOP rival, is also set to travel overseas.
Twitter drops labels for President Joe Biden, state-affiliated and government-funded media
The labels for both government officials and state-affiliated media were introduced in 2020 as part of an effort to protect political discourse on the platform.
Procter & Gamble beats earnings estimates, raises revenue forecast as prices rise
Procter & Gamble beat earnings expectations as higher prices helped offset lower demand for its products.
Senate legislation would cap insulin at $35 per month for people with private insurance
More than 2 million patients with diabetes who take insulin are privately insured, according to the Health and Human Services Department.
Treasury yields inch higher as Wall Street weighs latest economic data, next Fed rate move
U.S. Treasury yields rose slightly amid new round of economic data
